European Patent Office to Grant ToolGen, Inc. a patent on CRISPR-Cas9 system for genome editing
31 juil. 2018 08h30 HE
|
Toolgen, Inc.
SEOUL, South Korea, July 31, 2018 (GLOBE NEWSWIRE) -- ToolGen, Inc. (KONEX 199800) announced today that on July 26, 2018 the European Patent Office (EPO) issued a Decision to Grant to ToolGen a...
ToolGen, Inc., Demonstrates CRISPR/cas9 Gene Editing Improves Anti-Tumor Activity of Human CAR-T Cells
17 mai 2018 14h48 HE
|
Toolgen, Inc.
Knockout of T-Cell suppression pathway improves T-cell anti-tumor activity in a mouse glioblastoma model Data Presented at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting ...
ToolGen, Inc. Demonstrates Potential of CRISPR/cas9 Gene Editing to Overcome T-Cell Immunosuppression
11 déc. 2017 08h30 HE
|
Toolgen, Inc.
Potential Therapeutic Strategy to Target Tumors that Evade T-Cell Immune Response Data Presented at the 59th American Society of Hematology Annual Meeting SEOUL, South Korea, Dec. 11, 2017 (GLOBE...
ToolGen, Inc. Announces Poster Presentation on CRISPR Technology at 2017 American Society of Hematology Annual Meeting
28 nov. 2017 08h30 HE
|
Toolgen, Inc.
SEOUL, South Korea, Nov. 28, 2017 (GLOBE NEWSWIRE) -- ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, today announced a poster presentation on its CRISPR...
Monsanto and ToolGen Announce Global Licensing Agreement on CRISPR Platform, Underscore the Benefits of Innovation for Farmers
16 août 2017 08h30 HE
|
Toolgen, Inc.
ST. LOUIS and SEOUL, South Korea, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Monsanto Company (NYSE:MON) and ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, announced...
ToolGen, Inc. Announces Poster Presentation on Genome Editing of Human T Cells at 2017 American Society for Gene and Cell Therapy (ASGCT) Annual Meeting
15 mai 2017 08h30 HE
|
Toolgen, Inc.
SEOUL, South Korea, May 15, 2017 (GLOBE NEWSWIRE) -- ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, presented results from a study highlighting the use of...
ToolGen, Inc. Highlights Study Results Demonstrating Utility of AAV-Compatible Cas9 System in vivo Genome Editing
22 févr. 2017 08h30 HE
|
Toolgen, Inc.
SEOUL, South Korea, Feb. 22, 2017 (GLOBE NEWSWIRE) -- ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, today announced encouraging data from a study evaluating...